Woodline Partners’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-103,358
| Closed | -$346K | – | 929 |
|
|
2024
Q3 | $346K | Buy |
+103,358
| New | +$346K | ﹤0.01% | 550 |
|
|
2022
Q1 | – | Sell |
-208,399
| Closed | -$1.86M | – | 723 |
|
|
2021
Q4 | $1.86M | Buy |
208,399
+23,134
| +12% | +$207K | 0.03% | 432 |
|
|
2021
Q3 | $6.5M | Sell |
185,265
-2,540
| -1% | -$89K | 0.11% | 218 |
|
|
2021
Q2 | $4.03M | Sell |
187,805
-27,868
| -13% | -$599K | 0.08% | 244 |
|
|
2021
Q1 | $13.3M | Sell |
215,673
-60,410
| -22% | -$3.73M | 0.3% | 92 |
|
|
2020
Q4 | $11.5M | Buy |
+276,083
| New | +$11.5M | 0.31% | 100 |
|